Literature DB >> 31596742

Anti-BAFF Therapy: A New Tool to Target B Cells in Antibody-mediated Rejection?

Sarah E Panzer1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31596742      PMCID: PMC7012593          DOI: 10.1097/TP.0000000000002993

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   5.385


× No keyword cloud information.
  9 in total

Review 1.  BAFF AND APRIL: a tutorial on B cell survival.

Authors:  Fabienne Mackay; Pascal Schneider; Paul Rennert; Jeffrey Browning
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

2.  Anti-BAFF Treatment Interferes With Humoral Responses in a Model of Renal Transplantation in Rats.

Authors:  Louisa Steines; Helen Poth; Antonia Schuster; Edward K Geissler; Kerstin Amann; Bernhard Banas; Tobias Bergler
Journal:  Transplantation       Date:  2020-01       Impact factor: 4.939

3.  Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial.

Authors:  Gemma D Banham; Shaun M Flint; Nicholas Torpey; Paul A Lyons; Don N Shanahan; Adele Gibson; Christopher J E Watson; Ann-Marie O'Sullivan; Joseph A Chadwick; Katie E Foster; Rachel B Jones; Luke R Devey; Anna Richards; Lars-Peter Erwig; Caroline O Savage; Kenneth G C Smith; Robert B Henderson; Menna R Clatworthy
Journal:  Lancet       Date:  2018-06-14       Impact factor: 79.321

4.  Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.

Authors:  Sandra V Navarra; Renato M Guzmán; Alberto E Gallacher; Stephen Hall; Roger A Levy; Renato E Jimenez; Edmund K-M Li; Mathew Thomas; Ho-Youn Kim; Manuel G León; Coman Tanasescu; Eugeny Nasonov; Joung-Liang Lan; Lilia Pineda; Z John Zhong; William Freimuth; Michelle A Petri
Journal:  Lancet       Date:  2011-02-04       Impact factor: 79.321

5.  Peripheral B-cell phenotype and BAFF levels are associated with HLA immunization in patients awaiting kidney transplantation.

Authors:  Renaud Snanoudj; Sophie Candon; Dave L Roelen; Jean-Philippe Jais; Frans H Claas; Christophe Legendre; Lucienne Chatenoud
Journal:  Transplantation       Date:  2014-05-15       Impact factor: 4.939

6.  The expression of B-cell activating factor belonging to tumor necrosis factor superfamily (BAFF) significantly correlated with C4D in kidney allograft rejection.

Authors:  H Xu; X He; J Sun; D Shi; Y Zhu; X Zhang
Journal:  Transplant Proc       Date:  2009 Jan-Feb       Impact factor: 1.066

7.  Abnormal high expression of B-cell activating factor belonging to the TNF superfamily (BAFF) associated with long-term outcome in kidney transplant recipients.

Authors:  H Xu; X He; Q Liu; D Shi; Y Chen; Y Zhu; X Zhang
Journal:  Transplant Proc       Date:  2009-06       Impact factor: 1.066

8.  Elevated pretransplantation soluble BAFF is associated with an increased risk of acute antibody-mediated rejection.

Authors:  Gemma Banham; Davide Prezzi; Sarah Harford; Craig J Taylor; Rizwan Hamer; Rob Higgins; J Andrew Bradley; Menna R Clatworthy
Journal:  Transplantation       Date:  2013-08-27       Impact factor: 4.939

9.  B cell survival in intragraft tertiary lymphoid organs after rituximab therapy.

Authors:  Olivier Thaunat; Natacha Patey; Chantal Gautreau; Sophie Lechaton; Véronique Fremeaux-Bacchi; Marie-Caroline Dieu-Nosjean; Elisabeth Cassuto-Viguier; Christophe Legendre; Michel Delahousse; Philippe Lang; Jean-Baptiste Michel; Antonino Nicoletti
Journal:  Transplantation       Date:  2008-06-15       Impact factor: 4.939

  9 in total
  2 in total

1.  Metformin prevents BAFF activation of Erk1/2 from B-cell proliferation and survival by impeding mTOR-PTEN/Akt signaling pathway.

Authors:  Xiaoling Chen; Jing Ma; Yajie Yao; Jiawei Zhu; Zhihan Zhou; Rui Zhao; Xiaoqing Dong; Wei Gao; Shuangquan Zhang; Shile Huang; Long Chen
Journal:  Int Immunopharmacol       Date:  2021-05-15       Impact factor: 5.714

2.  BAFF signaling drives interstitial transformation of mouse renal tubular epithelial cells in a Pin1-dependent manner.

Authors:  Haiyan Xu; Dan Song; Renfang Xu; Xiaozhou He
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-06-14       Impact factor: 2.416

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.